Multiple sclerosis: which strategy goes beyond expectations?

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1634, 2008-01, pp. : 13-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Common Drug Review Recommendations: An Evidence Base for Expectations?

By Rocchi Angela Miller Elizabeth Hopkins Robert B. Goeree Ron

PharmacoEconomics, Vol. 30, Iss. 3, 2012-03 ,pp. : 229-246

Adis International

Access to resources Recommend Favorite

Can the Global Fund fulfil its expectations?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 457, 2004-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Preventing CMV infection - which strategy's best?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 283, 2000-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Which vaccination strategy for Africa's meningitis belt?

Inpharma, Vol. 1, Iss. 1220, 2000-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Which varicella vaccination strategy worth it in Italy?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 460, 2004-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite